WHO ICTRP trial
Observational Study in Patients with Geographic Atrophy Secondary to Age-related…
ACTRN12625000877482 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12625000877482 |
|---|---|
| Public title | Observational Study in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration |
| Scientific title | A Multicenter, OBSERVational Study in PatiEnts with Geographic Atrophy Secondary to Age-related Macular Degeneration (OBSERVE) |
| Primary sponsor | Kriya Therapeutics, Inc |
| Secondary sponsors | PPD Australia Pty Ltd |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | Australia;Canada;Israel;New Zealand;United Kingdom |
| Conditions | Geographic Atrophy; Geographic Atrophy;Eye - Diseases / disorders of the eye |
| Interventions | Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterized by atrophy of retinal tissues and typically occurs in individuals over the age of 50 years. In GA, the buildup of protein and lipid… |
| Registration date | Dec 8, 2025 |
| Target size | 120 |
| Secondary IDs | KRIYA-825-901 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: